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Abstract-Quantitative receptor autoradiography was used to determine the distribution of excitatory 
amino acid binding sites in the basal ganglia of rat brain. a-Amino-3-hydroxy-5-methylisoxazole-4- 
propionic acid, N-methyl-D-aspartate, kainate, quisqualate-sensitive metabotropic and non-N-methyl-D- 
aspartate, non-kainate, non-quisqualate glutamate binding sites had their highest density in striatum, 
nucleus accumbens, and olfactory tubercle. Kainate binding was higher in the lateral striatum but there 
was no medial-lateral striatal gradient for other binding sites. N-Methyl-D-aspartate and a-amino-3- 
hydroxy-5-methylisoxazole-4-propionic acid binding sites were most dense in the nucleus accumbens and 
olfactory tubercle. There was no dorsal-ventral gradient within the striatal complex for the other binding 
sites. Other regions of the basal ganglia had lower densities of ligand binding. To compare binding site 
density within non-striatal regions, binding for each ligand was normalized to the striatal binding density. 
When compared to the striatal complex, a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and 
metabotropic binding sites had higher relative density in the globus pallidus, ventral pallidum, and 
subthalamic nucleus than other binding sites. Metabotropic binding also had a high relative density in 
the substantia nigra. Non-N-methyl-D-aspartate, non-kainate, non-quisqualate glutamate binding sites 
had a high relative density in globus pallidus, ventral pallidum, and substantia nigra. N-Methyl-D-aspar- 
tate binding sites had a low relative density in pallidum, subthalamic nucleus, substantia nigra and ventral 
tegmental area. 
Our data indicate heterogeneous distribution of excitatory amino acid binding sites within rat basal 
ganglia and suggest that the character of excitatory amino acid-mediated neurotransmission within the 
basal ganglia is also heterogeneous. 
The basal ganglia are a group of interconnected 
subcortical nuclei spanning the telencephalon, dien- 
cephalon, and mesencephalon. While the functions of 
the basal ganglia are incompletely understood, it is 
known from both human clinical and experimental 
animal studies that the basal ganglia are involved in 
the organization of a wide variety of motor and 
non-motor behaviors. Biochemical, physiological, be- 
havioral, and immunocytochemical data indicate that 
excitatory amino acids (EAAs) are important neuro- 
transmitters of afferents to basal ganglia nuclei and of 
some circuits within the basal ganglia (see below). 
The best studied of these pathways is the corticostri- 
ate projection, where biochemical,6~13~24~29~30~40~“~70.75.80.94 
physiologica1,43.44.90.9’ immunocytochemical,2’ and 
[3H]D-aspartate retrograde tracing studies” have pro- 
vided strong evidence that the primary neurotrans- 
*To whom correspondence should be addressed at: Neurol- 
ogy Service, Massachusetts General Hospital. Boston, 
MA 02114, U.S.A. 
Abbreviahons: AMPA, a-amino-3-hydroxy-5-methylisoxa- 
zole4-propionic acid; EAA, excitatory amino acid; EP, 
entopeduncular nucleus; GP, globus pallidus; NMDA, 
N-methyl-D-aspartate; NNKQ, non-NMDA, non- 
kainate, non-quisqualate; OT, olfactory tubercle; PPN, 
pedunculopontine nucleus; SN, substantia nigra; STN, 
subthalamic nucleus; VP, ventral palladium; VTA, 
ventral tegmental area. 
mitter of corticostriate neurons is an EAA. In 
addition, other striatal afferents, including those from 
the amygdala,26 the parafascicular nucleus,26 and the 
subthalamic nucleus (STN)2,77 may utilize EAAs as a 
neurotransmitter. Other basal ganglia nuclei appear 
to receive EAAergic inputs. Recent physiological and 
immunocytochemical studies suggest that the STN, 
which sends substantial projections to the pallidum 
and substantia nigra (SN), is excitatory and uses an 
EAA as its neurotransmitter.2~38,62~77 Biochemical and 
tract-tracing studies have suggested that there is an 
EAAergic projection to the SN and ventral tegmental 
area (VTA) from the frontal cortex.7,‘0.‘7,53 The STN 
itself appears to receive a large projection from cortex 
and physiological evidence indicates that this pro- 
jection is EAAergic.‘.49,7s,79. 
EAA receptors have been subdivided into subtypes 
based on their response to relatively selective agon- 
ists.56.98 These receptors appear to possess distinctive 
physiological properties.56,98 The kainate receptor, 
and the quisqualate-sensitive and a-amino-3-hy- 
droxy-5-methylisoxazole-4-propionic acid (AMPA)- 
sensitive receptor mediate conventional fast synaptic 
neurotransmission by activation of ligand-gated ion 
channels. The N-methyl-D-aspartate (NMDA) recep- 
tor activates a cation channel which is gated by 
magnesium in a voltage-dependent fashion. NMDA 
receptors are thought to mediate some forms of 
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synaptic plasticity.‘“~5h A quisqualate-sensitive. but 
AMPA-insensitive EAA receptor coupled to inositol 
phospholipid metabolism (the metabotropic recep- 
tor) has been described recently.*’ The metabotropic 
receptor presumably produces neuromodulation 
rather than conventional fast neurotransmission. In 
addition to these relatively well-characterized recep- 
tor subtypes, we have described recently a neuronal 
[3H]glutamate binding site of unknown physiological 
significance and unique pharmacology.32 This non- 
NMDA. non-kainate. non-quisqualate (NNKQ) 
[‘HIglutamate binding site has a unique regional 
distribution within the CNS and undergoes signifi- 
cant changes in regional distribution during postnatal 
development.32 The existence of EAA receptor sub- 
types with distinctive physiological characteristics 
suggests that the postsynaptic effects of EAAs at a 
given synapse or within a given region are likely to be 
complex and possibly related to the relative density of 
EAA receptor subtypes. EAA receptor subtype distri- 
bution within the basal ganglia may play a major role 
in determining the character of EAA-mediated 
ncurotransmission within specific basal ganglia 
nuclei. 
Previous autoradiographic studies have identified 
EAA receptor subtypes within the basal 
gang~ia,13.~7,?7,5x,~~,7~,Y3 No study, however. has system- 
atically analysed the distribution of all EAA receptor 
subtypes in these nuclei. Recent refinements in auto- 
radiographic assays permit better delineation of EAA 
binding sites. As a prelude to further studies on EAA 
function within the basal ganglia we used quantitative 
receptor autoradiography to determine the distri- 
bution of EAA binding sites within the basal ganglia 
of the rat. 
EXPERIMENTAl, PROCEDURES 
[‘HJGlutamate (specific activity, 46 Ci!mmol) and 
[‘Hlkainate (specific activity, 4.4 Ciimmoll were nurchased 
from Amersham Inc. (Arlington Heights,’ IL). [<H]AMPA 
(specific activity. 29 Ci/mmol) was purchased from 
DuPont/NEN (Boston, MA). Non-radioactive quisqualate. 
AMPA and NMDA were purchased from Cambridge 
Research Biochemicals Inc. (Valley Stream, NY). The 
remaining reagents were purchased from Sigma Chemicals 
(St Louis, MO) and were of the highest possible purity. 
Tissue prepurution 
Fifteen male SpragueeDawley rats (Harlan Labs. 
Indianapolis, IN; weight, 175. 200 g) were decapitated, their 
brains rapidly removed and frozen in powdered dry ice. 
Twenty-micrometer-thick sections were cut on a Lipshaw 
cryostat. Eight animals were sectioned in the coronal plane 
at five different rostrocaudal levels. These levels included 
the caudoputamen-nucleus accumbens-olfactory tubercle 
COT), the globus pallidus (GP)-ventral pallidurn (VP), the 
entopeduncular nucleus, the STN. and the SN -VTA. Seven 
animals were sectioned in a parasagittal plant at two 
different levels approximately I.9 and 2.4 mm from the 
midline.6x Sections were thaw-mounted onto gelatin-coated 
slides on a warming plate and stored at -20 C until the 
time of assay. All assays were run 2448 h after being killed. 
Eight animals (four cut in the coronal plane and four cut in 
the sagittal plane) were used for assay of kainate and 
NNKQ binding sites. Seven animals (four cut coronally 
and three parasagittally) were used for assay of AMPA. 
metabotropic and NMDA binding sites. 
Receptor autorudiogrrrph~ 
Triplicate slides for assay of both total and nonspecific 
binding of each binding site were obtained at every level ol 
sectioning. Quantitative receptor autoradiography for 
AMPA and kainate binding sites was performed with 
[‘HIAMPA and [‘Hlkainate, respectively,. using conven- 
tional autoradiographic techniques (Table I).‘” NMDA 
binding sites were assayed with ‘[3H]glutamate in the pres- 
Table I. Conditions for excitatory amino acid binding site assays* 






60 nM 50 mM 2.5 /IM QUIS I mM NMDA 
Tris-acetate IOOpM KA 
pH 7.4 
34nM 50 mM I mM GLU 
Tris -HCI + 
2.5 mM CaClz 
+ 30 mM KSCN 
pH 7.2t 
100 nM 50 mM IOOpM NMDA 2.5pM QUIS 
Tris+HCl + IOpM AMPA 
2.5 mM CaCIZ 
+ 30 mM KSCN 
pH 1.21_ 
60 nM 50 mM IOOpM KA 
Tris-acetate 
pH 1.2 
200 nM$ 50 mM I mM NMDA I mM GLU 
Tris--HCl + 2.5 PM QUIS 
2.5 mM CaCl? ImMKA 
pH 7.2 
*All steps performed at 4°C. 
tRinse buffer without KSCN. 
$Specific activity diluted to 6.9 Ci/mmol with non-radioactive glutamate (GLU). 
KA, kainate; MET. metabotropic; QUIS, quisqualate. 
Basal ganglia glutamate receptors 37 
ence of blocking agents (Table l).% Metabotropic binding 
sites were assayed with [3H]glutamate in the presence of 
selective blockers according to the method of Cha et a1.14 
(Table 1) and the NNKQ binding sites were assayed with 
f3H]glutamate as previously described (Table 1).13 
For kainate binding sites, the ~ncentration of radioactive 
ligand was 60 nM and nonspecific binding was assessed with 
the addition of 100 @M kainate. For AMPA binding sites, 
the concentration of [3H]AMPA was 34 nM, and nonspecific 
binding was assessed with the addition of 1 mM glutamate. 
For NMDA binding sites, the concentration of [3H]- 
glutamate was 60 nM and nonspecific binding was assessed 
with addition of 1 mM NMDA. Metabotropic binding site 
density was assayed with IOOnM [3H]glutamate, and non- 
specific binding was measured with the addition of 2.5 nM 
quisqualate. NNKQ binding sites were measured with 
30 nM [‘HIglutamate diluted with 170 nM non-radioactive 
glutamate (final specific activity, 6.9 Ci/mmol) in the pres- 
ence of 1 mM NMDA, I mM kainate, and 2.5pM 
quisqualate, and nonspecific binding was measured with 
1 mM giutamate. For AMPA, kainate, and NMDA bind- 
ing, nonspecific binding represented less than 10% of total 
binding. Nonspecific binding was approximately 25% of 
total NNKQ binding and approximately 50% of total 
metabotropic binding. 
All assays were performed in an identical manner. Slides 
were warmed to room temperature, immersed in incubation 
buffer at 4°C for 30min and dried under a stream of cool 
air. Sections were then placed in incubation buffer at 4’C 
containing a single concentration of radioactive ligand 
(Table 1) and appropriate blocking agents (Table 1) for 
45 min. Incubation was terminated by removal of slides 
from the ligand solution and rapid rinsing with four 4-ml 
squirts of 4°C buffer followed by two 3-ml squirts of 2.5% 
glutaraldehyde in acetone. Slides were then dried under a 
stream of hot air and apposed to tritium-sensitive film 
(Hyperfilm, Amersham) in light-tight cassettes along with 
standards containing known amounts of radioactivity. After 
two to six weeks, films were developed in Kodak D-19. 
Data analysis 
Ligand binding was quantitated with computer-assisted 
densitometry using the MCID system (Imaging Research 
Inc., St Catharines, Ontario). To quantify ligand binding 
density, the optical density of co-exposed standards was 
determined and a standard curve generated by fitting stan- 
dard values with a fourth-degree polynomial regression 
equation.67 Standards were either specially made i4C plastic 
standard@’ or commercial 14C plastic standards (ARC Inc., 
St Louis, MO), both calibrated-against previously described 
‘H-brain paste standardse’ The ‘H-brain naste standards 
are constructed to give a known amount of radioactivity per 
picomole of protein. 67 Use of the standards and derived 
standard curve allows conversion of area1 optical density to 
pmol/mg protein values, 67 This technique does assume, 
however, that protein concentration is reasonably uniform 
across brain regions. Areas read included the medial stria- 
turn, lateral striatum, nucleus accumbcns, OT, GP, ventral 
pallidum (VP), entopeduncular nucleus (EP), STN, and 
VTA. Medial striatum and lateral striatum were read separ- 
ately because hodological and behavioral studies indicate 
that these areas have different functional features.9.f5.7’ The 
striatum viewed in the coronal plane was bisected to dis- 
tinguish lateral striatum from medial striatum. When com- 
paring data from lateral striatum and medial striatum, only 
readings from coronally sectioned animals were used. It was 
impossible to reliably differentiate substantia nigra pars 
compacta from substantia nigra pars reticulata and SN 
readings are an aggregate of the two regions weighted 
towards the pars reticulata because of its greater extent. All 
regions were read with a variable size cursor to allow 
sampling of the entire area of the structure(s) of interest 
present on each film. Assay of receptors with a single 
concentration of ligand does not allow strict comparison of 
receptor subtype density. Performance of saturation or 
displacement curves for small structures such as the STN, 
EP, and VTA is quite difficult. To assess the relative density 
of receptor subtypes within non-striatal basal ganglia nuclei, 
we normalized the density of binding sites within non- 
striatal nuclei by calculating the percentage of striatum- 
nucleus accumbens-QT complex binding site density for 
binding sites within non-striatal nuclei (Table 2). Since 
receptor density for all ligands (see below) was quite high in 
the striatal complex, the percentage of striatal binding serves 
as a basis for a comparative index of absolute receptor 
density. 
Differences between the amount of given ligand bound 
within different areas of the same region were assessed with 
a paired f-test. Areas compared with the r-test included the 
lateral striatum and medial striatum, dorsal striatum (mean 
of lateral striatum and dorsal striatum from the coronally 
sectioned animals averaged with dorsal striatum from 
parasagittally sectioned animals) and ventral striatum 
(mean of nucleus accumbens and OT), and the GP and 
VP. To compare statistically the density of different binding 
sites within non-striatal regions, the percentages of striatal 
complex binding for each binding site in each non-striatal 
region were compared with each other using one-way analy- 
sis of variance followed by post hoc Newman-Keuls testing 
for individual comparisons. 
RESULTS 
Striatum-nucleus accumbens-olfactory tubercle 
Among basal ganglia nuclei, these three regions 
had the highest density of all EAA binding sites 
(Table 2, Figs l-4). With the exception of kainate 
binding, the density of ligand binding was similar 
between the medial striatum and lateral striatum 
(Tables 2, 3. Figs 1, 3). Kainate binding sites were 
slightly but significantly more dense in the lateral 
striatum (Tables 2, 3, Fig. 3). Kainate, metabotropic, 
and NNKQ binding sites had similar density in the 
striatum, nucleus accumbens, and OT (Tables 2, 3, 
Figs 1, 3, 4). NMDA and AMPA binding sites, 
however, had a dorsal-ventral density gradient with 
highest density of binding in the nucleus accumbens 
and OT (Tables 2, 3, Figs 1, 2). 
Globus pallidus-ventral pallidurn 
In all assays the density of ligand binding was 
substantially lower in the GP and VP than in the 
striatum-nucleus accumbens-OT (Table 2, Figs l-4). 
VP, however, had a consistently higher density of 
bound ligand than GP (Tables 2, 3, Figs l-4). 
Relative to the striatal regions, there were some 
differences between receptor subtypes in the GP-VP. 
GP, NMDA and kainate binding sites had particu- 
larly low densities relative to the striatum (Tables 2, 
3, Figs 2, 3). AMPA, metabotropic, and NNKQ 
binding sites had greater relative densities than 
NMDA or kainate binding sites in the GP (Tables 2, 
3) and these differences were statistically significant 
(Table 3). In the VP, metabotropic, kainate, AMPA, 
and NNKQ binding had higher relative densities than 
NMDA binding sites (Tables 2, 3). Analysis of 
variance indicated that metabotropic, kainate, 
AMPA, and NNKQ binding sites comprised a single 
38 R. L. AI.HIN PI ai. 
Table 2. Density of excitatory amino acid binding sites in rat basal ganglia 
Region NMDA AMPA MET KA NNKQ 
Lateral striatumt 0.673 2.417 0.694 1.044 I.513 
(0.016) (0.03 1) (0.053) (0.172) (0.193) 
Medial striatumf 0.676 2.559 0.738 0.958 1.493 
(0.06) (0.082) (0.076) (0.179) (0.140) 
Dorsal striatum$ 0.68 2.287 0.734 0.894 1.500 
(0.016) (0.105) (0.035) (0.091) (0.167) 
Nucleus accumbens I.002 2.712 0.767 0.9843 1.527 
(0.039) (0.286) (0.084) (0.091) (0.133) 
OT I .25 2.583 0.834 I.015 1.373 
(0.063) (0.322) (0.093) (0.093) (0.140) 
Ventral striatum~ 1.127 3.66h 0.818 0.997 I .421 
(0.03 I) (0.309) (0.084) (0.133) 
Striatal complex* 0.903 2.467 
(~:~~~) 
0.975 I so0 
Globus pallidus 0.081 0.626 0.1X1 0.138 0.533 
(0.012) (0.054) (0.03) (0.01) (0.060) 
90/O 25% 23% 14% 369/o 
VP 0.173 0.X64 0.363 0.443 0.740 
(0.033) (0.036) (0.045) (0.030) (0.0X7) 
t90,b 3 5 “; 47% 45% 49% 
EP 0.064 0.4 i 0.159 0.233 0,280 
(0.006) (0.010) (0.030) (0.037) (0.027) 
7% 16% 21% 23% I 9% 
STN 0.161 0.77x 0.377 0.285 0.223 
(0.015) (n.05 I t (0.059) (0.042) (0.053) 
IX% 3 1 % 49% 29% I 5% 
SN 0.1 12 0.578 0.259 0.193 0.613 
(0.014) (0.025) (0.0311) (0.042) (0.040) 
12% 23% 34% 20% 4 t %, 
VTA 0.188 0.450 0.1 1 0.148 0.360 
(0.031) (0.030) (0.05 I ) (0.047) (0.053) 
20% I 8 % 14% 15% 24% 
Units are pmol/mg protein (S.E.M.). Percentages are percentage of binding in region as percentage of binding in the striatal 
compiex.* 
*To correct for the greater extent of the dorsal striatum, the striatal complex mean was calculated by adding mean of dorsal 
striatum twice to means of nucleus accumbens and OT and dividing by four. 
tMedial and lateral striatum measurements from animals sectioned in coronal plane. 
iMean of lateral and medial striatum in coronal sections averaged with striatum from parasagittal sections. 
§Mean of nucleus accumbens and OT. 
KA, kainate; MET, metabotropic. 
t-Test results* 
Table 3. Results of statistical analysis 
Regions compared NMDA AMPA MET KA NNKQ 
Lateral striatum vs medial striatum 
Dorsal striatum vs ventral striatum 
GP vs VP 
NS NS NS P < 0.025 NS 
P < 0.001 P < 0.05 NS NS NS 








P < O.OOUi; NNKQ > MET(P < 0.05), KA(P < O.Ol), NMDA(P < 0.01). 
AMPA > KA(P < 0.05), NMDA(P < O.Ol), MET > NMDA(P i 0.05) 
P < 0.001: NNKO. KA. MET, AMPA > NMDA(P < 0.05) 
P < 0.02; NNKQ:‘KA, MET > NMDA(P < 0.05) 
P < 0.0001; MET > NNKQ(P < 0.01) KA(P < O.Ol), AMPA 
(P < 0.05), NMDA(P < 0.01) 
P < 0.0001; NNKQ > NMDA(P < O.Oi), AMPA(P < 0.01). 
MET@ < 0.05), KA(P < O.Oi), MET > NMDAfP < 0.01) 
NS 
*Results of paired t-test. 
tResults of analysis of variance with significance of one-way ANOVA followed by results of significant pas! hoc 
Newman-Keuls individual comparisons. Individual Newman-Keuls comparisons that are not significant are not shown. 
KA. kainate; MET. metabotropic; NS, not significant. 
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Fig. 2. Histograms of NMDA and AMPA binding site density in the basal ganglia. Error bars are S.E.M. 
STRL, lateral striatum; STRM, medial striatum; STRD, dorsal striatum; ACC, nucleus accumbens; 
STRV, ventral striatum. 
group which was significantly different from NMDA of the latter four binding sites forming one group 
binding sites (Table 3). (Table 3). 
Entopeduncular nucleus Subthalamic nucleus 
This region had a low relative density of all binding The relative density of NMDA and NNKQ bind- 
site subtypes (Table 2, Figs l-4). As with the VP, the ing sites was low (Tables 2, 3, Figs 2, 4). AMPA and 
relative density of NMDA binding sites was lower kainate binding site densities were almost one-third 
than AMPA, metabotropic, kainate, and NNKQ of striatal complex binding and metabotropic binding 
relative binding site density with the relative densities site density was almost 50% of striatal complex 
Fig. 1. Parasagittal autoradiographs of EAA binding sites in the basal ganglia. (A) NMDA, (B) AMPA, 
(C) metabotropic, (D) kainate, (E) NNKQ. STR, dorsal striatum; ACC, nucleus accumbens. Metabo- 
tropic binding site image prepared by digital subtraction of [3H]glutamate binding under metabotropic 
binding site conditions (see Table I and text) in the presence of 2.5 PM quisqualate from total 
[3H]glutamate binding under metabotropic binding site conditions. Digital subtraction is done by 
computationally superimposing images from two closely adjacent sections and computing the difference 
of superimposed pixels. An image is constructed using the derived values for individual pixels. Digital 
subtraction is done with images from this assay because of the relatively high nonspecific binding. 
Magnification = x 10 prior to reduction. 
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MET 
KA 
Fig. 3. Histograms of metabotropic (MET) and kainate (KA) binding site density in the basal ganglia 
Abbreviations and error bars as for those of Fig. 2. 
binding (Table 2, Figs 2, 3). Only the relative density 
of metabotropic binding was statistically distinguish- 
able from the relative density of other binding sites 
(Table 3). 
Substantia nigra-ventral tegmental area 
The relative density of all binding sites was low in 
SN and VTA with the exception of metabotropic and 
NNKQ binding in the SN (Tables 2, 3, Figs l-4). The 
latter was approximately 40% of striatal complex 
binding (Table 2, Fig. 4). The relative densities of 
metabotropic and NNKQ binding were significantly 
different from the relative densities of the other 
binding sites (Table 3). There were no significant 
differences among relative densities of binding sites in 
the VTA (Tables 2. 3). 
DISCUSSION 
All nuclei of the basal ganglia possessed EAA 
binding sites but EAA binding site subtypes were 
distributed inhomogeneously in rat basal ganglia. 
Strict comparison of the total density (B,,,) of bind- 
ing site subtypes within a given region was not 
possible using single ligand concentrations. Scatchard 
analyses, however, were not feasible in several regions 
due to their small size. Nonetheless, by comparing the 
amount of bound ligand relative to binding within the 
striatum-nucleus accumbens-OT complex, a region 
with a high density of all EAA binding site subtypes, 
it is possible to approximate the relative density of 
EAA binding site subtypes within and among basal 
ganglia nuclei. This type of analysis assumes that 
Basal ganglia glutamate receptors 
NNKQ 
43 
Fig. 4. Histogram of NNKQ binding site density in the basal ganglia. Abbreviations and error bars as 
for Fig. 2. 
receptor affinity is reasonably similar in different 
basal ganglia nuclei. Prior studies of EAA binding 
sites have found little variation in the affinity of EAA 
binding sites between regions with the exception of 
NMDA binding sites which may exist in both ago- 
nist-preferring and antagonlst-preferring forms in 
different regions.3JS5E*59 
The binding site density differences between basal 
ganglia nuclei are most marked by the higher density 
of all binding sites in the striatum-nucleus 
~um~ns~T complex than other nuclei of the 
basal ganglia. Of all basal ganglia nuclei, the 
striatum-nucleus accumbens-OT complex probably 
receives the greatest amount of EAAergic inner- 
vation. In addition to the massive and weil- 
characterized input from neocortex to the striatum 
proper, 23,24.29,30,40.54,10,75.80,94 the striatum-nucleus 
accumbens-OT complex also receives probable 
EAAergie input from the hippocampal complex,” 
amygdala,26*94,95 and primary olfactory cortex.‘6 The 
striatum-nucleus accumbens-QT complex may also 
receive EAAergic afferents from the intralaminar 
nuclei of the thalamus. Retrograde rHfr>-aspartate 
transport studies indicate that these nuclei may be 
EAAergic. 26 Studies of striatal EAA uptake after 
parafascicular nucleus lesions, however, do not sup- 
port this notion. 5s The striatal complex also receives 
a potentially EAAergic input from the STN. While 
the STN-striatal projection is relatively modest in 
rat 36.48 in primates and cat it appears to be a more 
sudstantiaf striataf afferent.8t”8 The relatively high 
density of ah EAA binding sites within ait com- 
ponents of the striatum-nucleus accumbens-OT 
complex emphasizes the similarity of dorsal striatum, 
nucleus accumbens, and OT.’ 
Our NMDA, AMPA, and kainate data are consist- 
ent with previous studies of striatal EAA binding sites 
in rat brain.33137,57.5**60.93 Our results correlate with 
studies showing that intrastriatal infusion of agents 
active at either NMDA, AMPA, or kainate receptors 
produce prominent behavioral effects.22+4’*45*85 Our
metabotropic binding data are also compatible with 
evidence that glutamate and quisqualate agonists are 
potent stimulators of inositof phospho~jpid turnover 
in striatal slices and striatal neurons in primary 
culture.64*a3~q” Autoradiographic investigations of 
inositol triphosphate receptors have shown a high 
density in the striatum. 97 Available data suggest that 
EAA binding sites are predominantly located on 
striatal neurons though some data suggests the pres- 
ence of presynaptic EAA receptors on corticostriate 
and nigrostriatat dopaminer~c terminals.iS*u~3’ 
Within the striatum-nucleus accumbens-OT com- 
plex, our results suggest differences in EAA binding 
site distribution. Kainate binding was significantly 
higher in the Lateral striatum than the medial stria- 
turn, and there is a dorsal-ventral gradient of NMDA 
and AMPA binding site density with highest density 
in the ventral striatum and lowest in the dorsal 
striatum. One possible explanation for this gradient 
is the greater cellular density of the nucleus accum- 
bens and OT, especially when compared with the 
dorsal striatum where it is penetrated by myelinated 
bundles of corticofugal axons. Myelin absorbs tri- 
tium emissions, and this “quenching” may cause 
underestimates of ligand bindingnZ7 Kainate, metabo- 
tropic, and NNKQ binding sites, however, have no 
dorsal-ventral density gradient. The distributions of 
these bmding sites cannot be attributed to neuronal 
density or white matter gradients and suggest that 
there is a real dorsal-ventral gradient in NMDA and 
AMPA binding site density. 
44 R. L. ALBIN CI id. 
Another dorsal-ventral gradient exists between the 
dorsal and ventral pallidum. In this situation, how- 
ever, all EAA binding site subtypes are more dense in 
VP than in GP. Due to the fact that the GP is 
traversed by numerous fibers of passage, neuronal 
density is higher in VP than GP. Difference in 
neuronal density is a likely explanation for the higher 
density of receptors and NNKQ binding in VP than 
in GP. In addition, many of the fibers passing 
through the GP are myelinated, and white matter 
quenching could contribute to the apparently lower 
density of EAA binding sites in GP. While binding 
studies with “C-labeled ligands would be necessary to 
systematically evaluate the possible role of quench- 
ing, our previous experience with [‘4C]glutamate 
binding suggests that white matter quenching is not 
a major dete~inant of regional differences in binding 
site density.“4 Within the GP. AMPA, metabotropic, 
and NNKQ binding sites had higher relative densities 
compared to the striatal complex than NMDA or 
kainate binding sites. GP receives potentially 
EAAergic inputs from the parafascicular nucleus,” 
and a substantial projection from the STN.48 VP also 
receives a projection from the STN’6 and Fuller er ~6. 
have used [3H]D-aspartate retrograde transport to 
show a potentially EAAergic afferent from the in- 
tralaminar thalamic nuclei.26 AMPA, metabotropic, 
kainate, and NNKQ binding sites had high relative 
densities within the VP. Despite the apparently low 
density of NMDA binding sites, behavioral studies 
indicate that NMDA receptors may play a significant 
role in pallidal function. Turski et of. have demon- 
strdted that intra-GP infusion of the NMDA antag- 
onist AP7 has significant effects on motor behavior.” 
The EP has a low density of all EAA binding sites 
with a particularly low density of NMDA binding 
sites. As with the GP, the low density of EAA binding 
sites could be due in part to the low cellular density 
of the EP and the fact that it is embedded within the 
fibers of the heavily myelinated internal capsule. 
Functional EAA receptors exist within the EP. Injec- 
tion of EAA antagonists within the EP of primates 
and rodents has potent effects on motor function.si,7h 
The EP receives a substantial EAAergic input from 
the STN. 
The STN itself is known to receive a prominent 
projection from the neocortex.’ Extracellular record- 
ing studies have established that the cortico-STN 
projection is responsible for a rapid onset, short 
duration EAA-mediated excitatory postsynaptic 
potential in STN neurons,49178.7y and the pharma- 
cology of this fast excitatory postsynaptic potential is 
consistent with activation of kainate or AMPA recep- 
tors.“.” These physiological results accord well with 
our binding data demonstrating a relatively high 
density of AMPA and kainate binding sites within the 
STN. Metabotropic binding sites are also relatively 
dense within the STN, suggesting that metabotropic 
receptors may be an important substrate for plastic 
changes in STN neuron function induced by cortical 
activity. While the relative density of NMDA binding 
sites in STN is low, a recent intracellular recording 
study indicated that NMDA receptors are involved in 
the afferent activation of STN neurons.63 
The STN provides excitatory, EAAergic input to 
the VTA-SN, including both the pars reticulata and 
pars compacta.4x,77 The VTA--SN may receive other 
EAAergic inputs. The existence of a corticonigral 
projection has been controversial, but tract-tracing 
studies indicate the presence of a frontal corticonigral 
projection which preferentially terminates on the pars 
compacta and VTA.‘,‘” Biochemical studies indicate 
that this projection is EAAergic.i3~‘7~52 The SN also 
receives an excitatory input from the pedunculopon- 
tine nucleus (PPN).*l The PPN-nigral projection has 
been thought to be cho1inergic3’ Scarnati ct d., 
however, have shown that SN neuron excitation 
induced by PPN stimulation is antagonized by EAA 
antagonists and not by the muscarinic antichohnergic 
scopolamine.82 The PPN projects also to the GP and 
EP. Recent studies of PPN connections indicate that 
non-cholinergic neurons closely adjacent to the 
cholinergic neurons of the PPN project to the GP. 
EP, and SN.S3 The PPN is another potential source 
of EAAergic innervation of the basal ganglia. 
The SN is distinguished by the presence of a high 
relative density of metabotropic and NNKQ binding 
sites. The NNKQ site has also been found to be 
relatively abundant in human SN.69 The functional 
significance of this binding site is presently unknown. 
Despite their low density, other types of EAA recep- 
tors may be important in SN-VTA function. Behav- 
ioral changes can be induced by intranigral infusion 
of kainate, NMDA, and AMPA.5.72,73 Electrophysio- 
logical studies have demonstrated that nigral and 
VTA neurons are excited by NMDA and inhibited by 
NMDA antagonists,‘9.25,“6 and NMDA enhances 
dopamine release from SN slice preparations.” In rat 
mesencephalic cell cultures, EAA-stimulated dopa- 
mine release is attenuated by both NMDA and 
non-NMDA antagonists.6’ Kalivas et ui. have 
suggested that NMDA and kainate receptors are 
differentially located on different subpopulations of 
mesencephalic dopaminergic neurons.@ The preferen- 
tial localization of NMDA receptors on dopamin- 
ergic nigrostriatal neurons is supported by the recent 
finding that NMDA receptors are preferentially 
depleted in the SN of Parkinson’s disease victims.” 
Clinical implications 
Our binding studies have potential clinical impli- 
cations. The presence of EAA binding sites within all 
nuclei of the basal ganglia suggests that EAAergic 
agents could be used therapeutically to modify basal 
ganglia function. Several groups have suggested 
that agents interacting with EAA receptors might 
be useful in pharmacotherapy of Parkinson’s dis- 
ease,‘2.28.5”,M,H4 and Carlsson and Carlsson have shown 
that systemic administration of the non-competi- 
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tive NMDA antagonist {( + )-5-methyl-10,l l-dihy- ingly offers a better target for pharmacological inter- 
dro-5H-dibenzo[a,d]cyclohepten 5,10-iminemaleate} vention. 
(MK-801) to catecholamine-depleted mice increases 
motor activity. ” Injection of competitive or non- CONCLUSION 
competitive NMDA antagonists into the striatum 
produces an increase in motor activity similar to that We have demonstrated the presence of EAA bind- 
seen with dopamine agonists,“,22,84,85 and infusion of ing sites in all nuclei of the basal ganglia. The 
NMDA antagonists into the EP, STN, or SN poten- distribution of EAA binding sites was heterogeneous 
tiates the effect of L-DOPA in monoamine-depleted both within and between basal ganglia nuclei. While 
rats.5’ The clinical usefulness of modifying the the presence of binding sites in receptor binding 
activity of non-striatal basal ganglia nuclei with assays does not guarantee the presence of neurotrans- 
systemically administered EAA antagonists may, mission mediated by that receptor,42 our results 
however, be limited by the relatively low density of suggest that EAA-mediated neurotransmission 
EAA binding sites in the GP, VP, EP, SN, VTA, and within the basal ganglia has a complex and hetero- 
STN. The high density of EAA binding sites in other geneous character. 
forebrain regions suggests that toxic effects might 
occur before therapeutic benefit is obtained from 
blockade of EAA receptors in non-striatal basal 
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